Needleless Injectors Market 2028 By Type, Product, Site of Delivery, Application, End Use, and Geography | The Insight Partners

report image

Needleless Injectors Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Liquid-Based, Projectile/Depot-Based, and Powder-Based); Product (Fillable, and Prefilled); Site of Delivery (Subcutaneous Injectors, Intramuscular Injectors, and Intradermal Injectors); Application (Vaccine Delivery, Insulin Delivery, Pain Management, and Others); End Use (Hospitals and Clinics, Home Care Settings, Research Laboratories, and Others), and Geography

Report Code: TIPRE00024183 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming


Needless injection systems are employed to administer liquid formulations, drugs, and vaccines to patients without a traditional needle piercing the skin. The demand for Needless injection systems has increased considerably in recent years as they improve immune response to vaccines, stops the risks of needles, and reduce healthcare costs. It allows self-medication and eliminates needle phobia. The benefits of the Needless injection system involve reusability and the ability to deliver drugs faster. It provides a wide range of drug delivery systems. The needle-free injection system results in less pain and is highly preferred by patients.


The "Global Needleless Injectors Market Analysis to 2028" is a specialized and in-depth study of the medical devices industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Needleless injectors market with detailed market segmentation by type, product, site of delivery, application, end use, and geography. The report provides key statistics on the market status of the leading Needleless injectors market players and offers key trends and opportunities in the market.MARKET SEGMENTATION

  •  Based on type, the global Needleless injectors market is segmented into liquid-based, projectile/depot-based, powder-based.
  •  On the basis of product, the market is segmented into fillable, prefilled
  •  On the basis of site of delivery, the market is segmented into subcutaneous injectors, intramuscular injectors, intradermal injectors.
  •  On the basis of application, the market is segmented into vaccine delivery, insulin delivery, pain management, others.
  •  On the basis of end use, the market is segmented into hospitals and clinics, home care settings, research laboratories, others.


  •  Rise in the numbers of diabetes patients.
  •  Rise in the cases of various chronic diseases.
  •  Rise in the incidence of communicable disease due to needle stick injuries.
  •  Rise in the demand for self-injection devices.
  •  Advantages of drug delivery technology.


  •  The restricted use of needle-free injection systems for intravenous administration is the major restraining factor for this market.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Needleless injectors market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Needleless injectors market in these regions.


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

Get more information on this report :


The report covers key developments in the Needleless injectors market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Needleless injectors market are anticipated to lucrative growth opportunities in the future with the rising demand for Needleless injectors in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Needleless injectors market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
  •  Antares Pharma, Inc.
  •  PharmaJet
  •  PenJet Corporation
  •  Medical International Technology, Inc.
  •  INJEX Pharma AG
  •  Crossject needle-free injection systems
  •  National Medical Products Inc.
  •  Valeritas, Inc.
  •  European Pharma Group
  •  Endo International plc
    The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

    Get more information on this report :

  • The List of Companies

    1. Antares Pharma, Inc.
    2. PharmaJet
    3. PenJet Corporation
    4. Medical International Technology, Inc.
    5. INJEX Pharma AG
    6. Crossject needle-free injection systems
    7. National Medical Products Inc.
    8. Valeritas, Inc.
    9. European Pharma Group
    10. Endo International plc
    11. Bioject Medical Technologies Inc.
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market


    Have a question?

    Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

    Speak To Analyst
    • $3000
    • $4550
    • $6550
    • $8550

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount